Reversal of obesity by targeted ablation of adipose tissue

Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective treatment has yet been found. Here, we report an antiobesity therapy based on targeted induction of apoptosis in the vasculature of adipose tissue. We used in vivo phage display to isolate a peptide motif (sequence CKGGRAKDC) that homes to white fat vasculature. We show that the CKGGRAKDC peptide associates with prohibitin, a multifunctional membrane protein, and establish prohibitin as a vascular marker of adipose tissue. Targeting a proapoptotic peptide to prohibitin in the adipose vasculature caused ablation of white fat. Resorption of established white adipose tissue and normalization of metabolism resulted in rapid obesity reversal without detectable adverse effects. Because prohibitin is also expressed in blood vessels of human white fat, this work may lead to the development of targeted drugs for treatment of obese patients.

[1]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[2]  D. Cheresh,et al.  Adhesion events in angiogenesis. , 2001, Current opinion in cell biology.

[3]  B. Zetter,et al.  Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.

[4]  E. Jupe,et al.  Prohibitin: Potential role in senescence, development, and tumor suppression , 1995, Experimental Gerontology.

[5]  Carlos F. Barbas,et al.  Phage display: a Laboratory manual , 2014 .

[6]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[7]  M. Reth,et al.  The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin‐related protein. , 1994, The EMBO journal.

[8]  H. Adèr,et al.  Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects. , 1995, Obesity research.

[9]  S. Cinti.  Anatomy of the adipose organ , 2000, Eating and weight disorders : EWD.

[10]  Erkki Ruoslahti,et al.  Membrane Dipeptidase Is the Receptor for a Lung-targeting Peptide Identified by in Vivo Phage Display* , 1999, The Journal of Biological Chemistry.

[11]  R. Leibel,et al.  Physiologic basis for the control of body fat distribution in humans. , 1989, Annual review of nutrition.

[12]  O. Ishiko,et al.  Involvement of angiogenesis in weight-loss in tumor-bearing and diet-restricted animals. , 2001, International Journal of Molecular Medicine.

[13]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[14]  Young-Bum Kim,et al.  PTP1B regulates leptin signal transduction in vivo. , 2002, Developmental cell.

[15]  S. Bacher,et al.  Prohibitin and prohibitone, ubiquitous and abundant proteins that are reluctant to reveal their real identity. , 1997, International archives of allergy and immunology.

[16]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[17]  R. Hammer,et al.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.

[18]  D. Allison,et al.  Years of life lost due to obesity. , 2003, JAMA.

[19]  S. Woods,et al.  Adiposity signals and the control of energy homeostasis. , 2000, Nutrition.

[20]  S. Leibowitz.  Brain peptides and obesity: pharmacologic treatment. , 1995, Obesity research.

[21]  R Pasqualini,et al.  Molecular addresses in blood vessels as targets for therapy. , 2001, Current opinion in chemical biology.

[22]  P. Kopelman.  Obesity as a medical problem , 2000, Nature.

[23]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[24]  W. Arap,et al.  Teratogenicity induced by targeting a placental immunoglobulin transporter , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Kim-Anh Do,et al.  Steps toward mapping the human vasculature by phage display , 2002, Nature Medicine.

[26]  P. Hall,et al.  Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. , 2001, Experimental cell research.

[27]  K. Frazer,et al.  Genomic interval engineering of mice identifies a novel modulator of triglyceride production. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Grivell,et al.  Prohibitins act as a membrane‐bound chaperone for the stabilization of mitochondrial proteins , 2000, The EMBO journal.

[29]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[30]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[31]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[32]  J. Clapham,et al.  Anti-obesity drugs: a critical review of current therapies and future opportunities. , 2001, Pharmacology & therapeutics.

[33]  F. Burrows,et al.  Vascular targeting--a new approach to the therapy of solid tumors. , 1994, Pharmacology & therapeutics.

[34]  S. Chellappan,et al.  Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis , 2002, Oncogene.

[35]  Matthias Blüher,et al.  Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.

[36]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Erkki Ruoslahti,et al.  Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.

[38]  R. Krauss,et al.  Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Folkman.  Addressing tumor blood vessels , 1997, Nature Biotechnology.

[40]  D. McConkey,et al.  The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. , 1996, Oncogene.

[41]  J. Folkman,et al.  Endothelial-Directed Hepatic Regeneration After Partial Hepatectomy , 2003, Annals of surgery.

[42]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[43]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[44]  D. L. Crandall,et al.  A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives , 1997, Microcirculation.